Press release
Keloids Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Sirnaomics, Yuhan Pharmaceuticals, Lemonex Inc., CellionBioMed
Keloids Pipeline Analysis
DelveInsight's analysis shows that over five major companies are actively engaged in the ongoing development of more than five treatment therapies for keloids.
Keloids Overview:
Keloids are a type of hypertrophic scar that extends beyond the original injury site, forming raised, irregular growths that do not regress over time. They commonly develop after skin trauma such as surgical incisions, burns, severe acne, or minor scratches. People with darker skin tones and a family history of keloids are more susceptible. These scars appear shiny and firm, with colors ranging from pink to dark brown and can cause itching, tenderness, or pain, especially when located over joints or high-movement areas.
Keloid formation results from excessive collagen production during wound healing, influenced by genetics, skin tension, and inflammatory responses. The imbalance in collagen synthesis and breakdown leads to the uncontrolled growth of scar tissue.
Diagnosis is clinical, based on the scar's appearance and history, though a biopsy may be used to rule out other conditions.
Treatment options focus on reducing size, alleviating symptoms, and preventing recurrence. Common treatments include:
*
Corticosteroid injections (to flatten and reduce inflammation)
*
Surgical removal (often combined with other therapies to lower recurrence risk)
*
Laser therapy & cryotherapy (to shrink and lighten keloids)
*
Silicone sheets & gels (to flatten and reduce discoloration)
*
Pressure or radiation therapy (for severe cases)
Prevention strategies include proper wound care, avoiding unnecessary skin trauma, and early use of silicone-based treatments to minimize keloid formation.
Request for a detailed insights report on Keloids pipeline insights @ https://www.delveinsight.com/report-store/keloids-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
"Keloids Pipeline Insight 2025" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Keloids Therapeutics Market.
Key Takeaways from the Keloids Pipeline Report
*
DelveInsight's Keloids pipeline report highlights a dynamic and expanding landscape, with over five active companies working on the development of more than five treatment candidates for keloids.
*
Notable companies in this space include Sirnaomics, Yuhan Pharmaceuticals, Lemonex Inc., CellionBioMed, and others, all exploring innovative therapies to enhance the current treatment options for keloids. Among the promising candidates in development is STP705, along with several others at various clinical stages.
*
A study published in Dermatologic Surgery assessed the effectiveness of combining intralesional bleomycin and triamcinolone for treating stubborn keloids. Among 33 patients, 78.8% achieved excellent improvement (75%-100% flattening), while 21.2% showed fair results (25%-75% flattening). However, some patients experienced side effects like ulceration and hyperpigmentation, highlighting the need for close monitoring during treatment.
*
Additionally, Soliton, Inc. tested its RAP device in a proof-of-concept trial, utilizing rapid acoustic shockwaves as a non-invasive therapy for keloid and hypertrophic scars. Just one six-minute session led to an average scar volume reduction of over 27% and a nearly 17% decrease in scar height within six weeks. Notably, there were no treatment-related adverse events, and patients reported minimal discomfort.
Keloids Pipeline Analysis
The report provides insights into:
*
The report provides detailed insights into the key companies that are developing therapies in the Keloids Market.
*
The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Keloids treatment.
*
It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
*
It navigates the emerging drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
*
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Keloids market.
Download our free sample page report on Keloids pipeline insights [https://www.delveinsight.com/sample-request/keloids-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Keloids Emerging Drugs
*
STP705: Sirnaomics
Keloids Companies
Over five major companies are currently working on developing treatments for keloids. Among them, Sirnaomics, Inc. has a drug candidate in Phase II clinical trials, marking the most advanced stage of development within this therapeutic area.
DelveInsight's report covers around 5+ products under different phases of clinical development like
*
Late stage products (Phase III)
*
Mid-stage products (Phase II)
*
Early-stage product (Phase I) along with the details of
*
Pre-clinical and Discovery stage candidates
*
Discontinued & Inactive candidates
Keloids pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
*
Intravenous
*
Subcutaneous
*
Oral
*
Intramuscular
Keloids Products have been categorized under various Molecule types such as
*
Monoclonal antibody
*
Small molecule
*
Peptide
Download Sample Pages to Get an in-depth Assessment of the Emerging Keloids Therapies and Key Companies: Keloids Clinical Trials and advancements [https://www.delveinsight.com/report-store/keloids-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Keloids Pipeline Therapeutic Assessment
- Keloids Assessment by Product Type
- Keloids By Stage
- Keloids Assessment by Route of Administration
- Keloids Assessment by Molecule Type
Download Keloids Sample report to know in detail about the Keloids treatment market @ Keloids Therapeutic Assessment [https://www.delveinsight.com/sample-request/keloids-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Table of Content
1. Report Introduction
2. Executive Summary
3. Keloids Current Treatment Patterns
4. Keloids - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Keloids Late-Stage Products (Phase-III)
7. Keloids Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Keloids Discontinued Products
13. Keloids Product Profiles
14. Keloids Key Companies
15. Keloids Key Products
16. Dormant and Discontinued Products
17. Keloids Unmet Needs
18. Keloids Future Perspectives
19. Keloids Analyst Review
20. Appendix
21. Report Methodology
Request the Sample PDF to Get Detailed Insights About the Keloids Pipeline Reports Offerings [https://www.delveinsight.com/report-store/keloids-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=keloids-clinical-trials-companies-therapeutic-assessment-therapies-treatment-algorithm-pipeline-analysis-sirnaomics-yuhan-pharmaceuticals-lemonex-inc-cellionbiomed]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Keloids Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Sirnaomics, Yuhan Pharmaceuticals, Lemonex Inc., CellionBioMed here
News-ID: 4136021 • Views: …
More Releases from ABNewswire
Why Tungsten Carbide Digital Blades are Essential for Precision Sign Making
Precision is the foundation of modern sign making. Whether cutting vinyl graphics, reflective films, PVC sheets, or composite boards, the quality of the blade directly determines edge clarity, dimensional accuracy, and production efficiency. As digital cutting systems continue to replace manual and mechanical methods, tungsten carbide digital blades have become a critical component in achieving consistent, high-quality results.
Digital Cutting Demands a Different Kind of Blade
Unlike traditional cutting, digital sign cutting…
Delegation from Navarre, Spain Visits HOUPU Clean Energy Group Co., Ltd. to Expl …
Chengdu, China - HOUPU Clean Energy Group Co., Ltd. (hereinafter referred to as "HOUPU"), a leading provider of clean energy equipment in China, recently welcomed a delegation from the regional government of Navarre, Spain. Led by Inigo Arruti Torre, Director-General of Economic Development and Infrastructure for the Government of Navarre, the delegation visited HOUPU's R&D and manufacturing facilities on November 20. The visit featured productive discussions focused on deepening cooperation…
PSC Turning Toolholder SCLCR/L - Industry Trends and Best Practices
Product Features
High Torque Transmission
Both surfaces of the tapered-polygon and flange are positioned and clamped, providing an extraordinary high torque transmission and High bending strength resulting in excellent cutting performance and increasing productivity.
High Basic Stability And Accuracy
By adapting PSC positioning and clamping, it is an ideal turning tool interface to guarantee repeated accuracy plus-minus 0.002mm from X, Y, Z axis, and reduce machine downtime.
Reduced Set-Up Time
Time of set-up and tool change…
CES 2026: Eforthink Redefines "Spatial Perception" Through High-Precision UWB In …
LAS VEGAS - At CES 2026, Eforthink took center stage with a comprehensive showcase titled "Spatial Perception," highlighting a strategic pivot toward integrating Ultra-Wideband (UWB) technology [https://www.eforthink.com/technology/uwb-high-precision-positioning-system/] into the fabric of both industrial intelligence and smart home ecosystems. As the consumer electronics industry shifts toward systematization, Eforthink's demonstration of centimeter-level accuracy suggests a future where devices don't just connect, but actively sense their physical environment.
Image: https://ecdn6-nc.globalso.com/upload/p/3548/image_other/2026-01/ces-exhibition-scene-picture-1-1.png
Industry 4.0: Achieving Full-Factor Lean…
More Releases for Keloid
Keloid Treatment Market Is Going to Boom |• Dermatology specialists • Keloid …
According to Worldwide Market Reports (WMR) highlights that the "Keloid Treatment Market" is projected to experience substantial growth in the coming years. This report provides a comprehensive analysis of the market landscape using an integrated approach that includes research methodology, market size evaluation, data compilation, and insights gathered from multiple credible sources.
The study covers critical market elements such as market dynamics, drivers, restraints, challenges, threats, growth opportunities, development trends, technological…
Hypertrophic and Keloid Scar Treatment Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Hypertrophic and Keloid Scar Treatment Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
Hypertrophic and Keloid Scar Treatment Market Size and Scope
The hypertrophic and keloid scar treatment market focuses on solutions designed to reduce, manage,…
Keloid Treatment Market: Intralesional corticosteroid injections to remain most …
According to the latest market report published by Future Market Insights titled‘Keloid Treatment Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027),’the global keloid treatment market is estimated to be worth US$ 3,145.8 Mn by 2017 end, and is expected to expand at a CAGR of 3.4% over the forecast period of 2017–2027 to reach a market valuation of US$ 4,414.6 Mn by the end of 2027.
To know key findings…
Keloid Treatment Market Professional Survey Report 2024
Global Keloid Treatment Market: Overview
The British Skin Foundation describes a keloid scar as an overgrown scar that spreads beyond the original area of the damaged skin. It is a growth of extra scar tissue in the place where the skin has healed post-injury. Keloids can appear anywhere on the body and affect an estimated 10-15% of all wounds.
Request Brochure-
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12152
There are several established treatment options available for keloid scars, including laser…
Keloid Treatment Market Professional Survey Report 2024
Global Keloid Treatment Market: Overview
The British Skin Foundation describes a keloid scar as an overgrown scar that spreads beyond the original area of the damaged skin. It is a growth of extra scar tissue in the place where the skin has healed post-injury. Keloids can appear anywhere on the body and affect an estimated 10-15% of all wounds. There are several established treatment options available for keloid scars, including laser treatment,…
Keloid Treatment Market, Industry Analysis, Research Report 2024
Global Keloid Treatment Market: Overview
The British Skin Foundation describes a keloid scar as an overgrown scar that spreads beyond the original area of the damaged skin. It is a growth of extra scar tissue in the place where the skin has healed post-injury. Keloids can appear anywhere on the body and affect an estimated 10-15% of all wounds. There are several established treatment options available for keloid scars, including laser…
